DNA RNA and Cells

26 Aug 2008 Novosom AG acquires exclusive license from Isis Pharmaceuticals, Inc. for CD40-targeted antisense inhibitors
25 Aug 2008 Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
22 Aug 2008 Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion
21 Aug 2008 Allogeneic, "Off-The-Shelf", Stem Cells Are Safe And Effective For Cervical Spine Fusion
19 Aug 2008 Neurologix Initiates Recruitment for Phase 2 Parkinson's Disease Trial
19 Aug 2008 Introgen's ADVEXIN(R) MAA Accepted for Review by European Medicines Agency
18 Aug 2008 Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well
14 Aug 2008 Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
14 Aug 2008 Dendreon Initiates Second of Two New Phase 2 Trials
14 Aug 2008 Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb
13 Aug 2008 Isis Initiates Clinical Trial of CRP Drug
13 Aug 2008 MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy against Seasonal and Pandemic Flu Strains
11 Aug 2008 Alnylam Forms Collaboration with Max Planck Institute to Investigate Biological Mechanisms for Cellular Uptake of RNAi Therapeutics
10 Aug 2008 Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
07 Aug 2008 Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen
06 Aug 2008 Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
06 Aug 2008 Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer
05 Aug 2008 Argos Therapeutics´ Arcelis™ Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial
31 Jul 2008 Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
31 Jul 2008 Preliminary Cerepro Phase III Results Meet Primary Endpoint
30 Jul 2008 Quark Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in DME
30 Jul 2008 Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of Epodure to Treat Anemia
26 Jul 2008 GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration to enable the discovery of new medicines
23 Jul 2008 TOPIGEN Pharmaceuticals Completes Enrollment of Phase II Clinical Study of TPI ASM8 in Asthma
23 Jul 2008 ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up